The Patent Finder

Sumitomo Pharma Oncology, Inc.

Also on record
Records under this name other than the patents Sumitomo Pharma Oncology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 24 patents it holds.

Back to Sumitomo Pharma Oncology, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,710,057Imidazo[1,2-b]pyridazine and Pyrazolo[1,5-a]pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,750,007Imidazo[1,2-beta]pyridazine and PYRAZOLO[1,5-Alpha]PYRIMIDINE Derivatives and Their Use as Protein Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,416,132Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,047,093Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,392,392Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,875,864Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,202,356JAK2 and ALK2 Inhibitors and Methods for Their Use
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,752,594JAK1 and ALK2 inhibitors and methods for their use
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,471,456Formulations Comprising Heterocyclic Protein Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,793,802Treatment of acute myeloid leukemia (AML) with venetoclax failure
Formerly held
In force
 · USPTO record
In forceUSPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited